Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zomedica Corp.ZOMDF · Entity 6884 | Director | November 17, 2025 | November 18, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zomedica Corp.
Report date November 17, 2025 · Filed November 18, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $0.10 · Expires 2035-11-16 | Direct | 1,823,107 |
Reported balance
After 2025-11-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-11-17 · Grant · Acquired 1,823,107 · Balance 1,823,107 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 17, 2025 Filed Nov 18, 2025 21:45 UTC | Zomedica Corp. ZOMDF · Entity 6884 | GrantStock Appreciation Right · Derivative | 1,823,107 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001654954-25-013227 · section16.xml · derivative · entry 1 Nichols Pamela · CIK 0001944747 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,823,107 Underlying: Common · 1,823,107 shares Expires 2035-11-16 Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 21:12 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantStock Appreciation Rights · Derivative | 1,975,033 | $0.00 Strike: $0.13 | $0.00 |
DisclosureSEC source: 0001654954-24-014269 · section16.xml · derivative · entry 1 Nichols Pamela · CIK 0001944747 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,975,033 Underlying: Common · 1,975,033 shares Expires 2034-11-10 Read SEC document |
| December 09, 2022 Filed Dec 13, 2022 23:36 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantOptions to Buy Common Stock · Derivative | 231,431 | $0.00 Strike: $0.19 | $0.00 |
DisclosureSEC source: 0001654954-22-016445 · section16.xml · derivative · entry 1 Nichols Pamela · CIK 0001944747 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,431 Underlying: Common Stock · 231,431 shares Expires 2032-12-09 F1 · derivative.exercise_date: The stock options vest annually in four equal installments commencing on December 9, 2023. Read SEC document |
| August 31, 2022 Filed Sep 2, 2022 20:17 UTC | Zomedica Corp. ZOM · Entity 6884 | GrantOptions to Buy Common Stock · Derivative | 800,000 | $0.00 Strike: $0.25 | $0.00 |
DisclosureSEC source: 0001654954-22-012131 · section16.xml · derivative · entry 1 Nichols Pamela · CIK 0001944747 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Stock · 800,000 shares Expires 2032-08-30 F1 · derivative.exercise_date: The stock options vest annually in four equal installments commencing08/31/2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.